Ditch Nvidia and Invest in This Outstanding Healthcare Stock Instead| The Motley Fool
Abbvie, a healthcare stock, has shown promising growth potential despite its lackluster returns this year, making it a more attractive investment option than Nvidia, which has a high valuation. Abbvie’s revenue growth has been impacted by the loss of exclusivity of its best-selling drug, Humira, but the company has offset this decline with the success … Read more